Intellia Therapeutics, Inc. (NASDAQ:NTLA) CAO Sells $38,248.12 in Stock
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report) CAO Michael P. Dube sold 2,012 shares of the stock in a transaction that occurred on Wednesday, October 2nd. The stock was sold at an average price of $19.01, for a total value of $38,248.12. Following the sale, the chief accounting officer now directly owns 47,012 shares […]
7 Oct 09:05 · The Markets Daily